Neoadjuvant therapy reduces the incidence of nodal micrometastases in esophageal adenocarcinoma

American Journal of Surgery

Volumn 206, Issue 5, 2013, Pages 732-738

  Wang, Da ^a   Smit, Justin K ^a   Zwaan, Eva ^a   Muijs, Christina T ^a   Groen, Henk ^a   Hollema, Harry ^a   Plukker, John T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Esophageal cancer; Neoadjuvant treatment; Nodal micrometastases

Indexed keywords

CAPECITABINE; CARBOPLATIN; CISPLATIN; EPIRUBICIN; PACLITAXEL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPH NODE METASTASIS; MALE; MICROMETASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SENTINEL LYMPH NODE METASTASIS;

ESOPHAGEAL CANCER; NEOADJUVANT TREATMENT; NODAL MICROMETASTASES;

ADENOCARCINOMA; CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING;

EID: 84886724447     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.03.004     Document Type: Article

References (29)

1. W.H. Hsu, P.K. Hsu, and C.C. Hsieh The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer J Gastrointest Surg 13 2009 1913 1920
2. C. Mariette, G. Piessen, and N. Briez The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent Ann Surg 247 2008 365 371
3. N.K. Altorki, X.K. Zhou, and B. Stiles Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2008 221 226
4. J.K. Smit, B.B. Pultrum, and H.M. van Dullemen Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy Am J Surg 200 2010 446 453
5. J.A. Hagen, S.R. DeMeester, and J.H. Peters Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies Ann Surg 234 2001 520 530 discussion; 530-1
6. T. Lerut, P. Nafteux, and J. Moons Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma Ann Surg 240 2004 962 972 discussion; 972-4
7. U. Zingg, M. Montani, and M. Busch Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer Eur J Surg Oncol 35 2009 593 599
8. P.A. Heeren, W. Kelder, and I. Blondeel Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction Eur J Surg Oncol 31 2005 270 276
9. K.L. Prenzel, A.H. Holscher, and U. Drebber Prognostic impact of nodal micrometastasis in early esophageal cancer Eur J Surg Oncol 38 2012 314 318
10. S.K. Thompson, A.R. Ruszkiewicz, and G.G. Jamieson Isolated tumor cells in esophageal cancer: implications for the surgeon and the pathologist Ann Surg 252 2010 299 306
11. M. de Boer, C.H. van Deurzen, and J.A. van Dijck Micrometastases or isolated tumor cells and the outcome of breast cancer N Engl J Med 361 2009 653 663
12. V. Gebski, B. Burmeister, and B.M. Smithers Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234
13. K.M. Sjoquist, B.H. Burmeister, and B.M. Smithers Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol 12 2011 681 692
14. W.H. Allum, S.P. Stenning, and J. Bancewicz Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer J Clin Oncol 27 2009 5062 5067
15. B.H. Burmeister, B.M. Smithers, and V. Gebski Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial Lancet Oncol 6 2005 659 668
16. D. Cunningham, W.H. Allum, and S.P. Stenning Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
17. K.L. Prenzel, A. Konig, and P.M. Schneider Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer Ann Surg Oncol 14 2007 954 959
18. A.C. Kole, J.T. Plukker, and O.E. Nieweg Positron emission tomography for staging of oesophageal and gastroesophageal malignancy Br J Cancer 78 1998 521 527
19. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
20. L.H. Sobin TNM, sixth edition: new developments in general concepts and rules Semin Surg Oncol 21 2003 19 22
21. D.L. Weaver Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale Mod Pathol 23 Suppl 2 2010 S26 S32
22. C.A. Makin, L.G. Bobrow, and W.F. Bodmer Monoclonal antibody to cytokeratin for use in routine histopathology J Clin Pathol 37 1984 975 983
23. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680 2686
24. P. van Hagen, M.C. Hulshof, and J.J. van Lanschot Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
25. E. Ancona, S. Rampado, and M. Cassaro Prediction of lymph node status in superficial esophageal carcinoma Ann Surg Oncol 15 2008 3278 3288
26. A.H. Holscher, E. Bollschweiler, and W. Schroder Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer Ann Surg 254 2011 802 807 discussion; 807-8
27. A.C. Berger, J. Farma, and W.J. Scott Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival J Clin Oncol 23 2005 4330 4337
28. J.M. Donahue, F.C. Nichols, and Z. Li Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival Ann Thorac Surg 87 2009 392 398 discussion; 398-9
29. P.M. Schneider, S.E. Baldus, and R. Metzger Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification Ann Surg 242 2005 684 692